High Qualified Enoxaparin Sodium Injection 40mg/0.4ml Anmedicine Ticoagulants

Product Details
Customization: Available
Application: Internal Medicine
Usage Mode: For external use
Still deciding? Get samples of $ !
Request Sample

360° Virtual Tour

Diamond Member Since 2025

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

High Repeat Buyers Choice
More than 50% of buyers repeatedly choose the supplier
Years of Export Experience
The export experience of the supplier is more than 10 years
Exhibition Experience
The supplier had participated in offline trade shows, you can check the Audit Report for more information
Experienced Team
The supplier has 18 foreign trading staff(s) and 6 staff(s) with over 6 years of overseas trading experience
to see all verified strength labels (26)
  • High Qualified Enoxaparin Sodium Injection 40mg/0.4ml Anmedicine Ticoagulants
  • High Qualified Enoxaparin Sodium Injection 40mg/0.4ml Anmedicine Ticoagulants
  • High Qualified Enoxaparin Sodium Injection 40mg/0.4ml Anmedicine Ticoagulants
  • High Qualified Enoxaparin Sodium Injection 40mg/0.4ml Anmedicine Ticoagulants
Find Similar Products

Basic Info.

Model NO.
AMC14084-01
Suitable for
Elderly, Children, Adult
State
Liquid
Shape
Injection
Type
Organic Chemicals
Pharmaceutical Technology
Chemical Synthesis
OEM/ODM
Support
Standard Available
Bp, Cp
Model No.
Amc14084-01
Function
Antibiotic
Transport Package
40mg/0.4ml
Specification
40MG/0.4ML
Trademark
Shinepharm
Origin
China
HS Code
300490909
Production Capacity
1000000 Boxes/Month

Product Description

High Qualified Enoxaparin Sodium Injection 40mg/0.4ml Anmedicine Ticoagulants

 

Indications:
Enoxaparin sodium injection is a low molecular weight heparin indicated for:
Prophylaxis of deep vein thrombosis (DVT) in abdominal surgery, hip replacement surgery, knee replacement surgery, or medical patients with severely restricted mobility during acute illness
Inpatient treatment of acute DVT with or without pulmonary embolism
Outpatient treatment of acute DVT without pulmonary embolism
Prophylaxis of ischemic complications of unstable angina and non-Q-wave myocardial infarction.
Treatment of acute ST-segment elevation myocardial infarction [STEMI] managed medically or with subsequent percutaneous coronary intervention [PCI]
Dosage and Administration:
Evaluate all patients for a bleeding disorder before starting enoxaparin sodium injection treatment, unless treatment is urgently needed.
Do not administer enoxaparin sodium injection by intramuscular injection.
Administer enoxaparin sodium injection by intravenous or subcutaneous injection only.

Storage instructions:

Store in a cool and dry place,below 25°C.

Testing terms Standards Results
Character A clear, colorless to pale yellow liquid. A clear, faint yellow liquid.
pH 5.5-7.5 6.7
Clarity and color Clear
Colour: BY5 or better
Clear
<Y5
Bacterial endotoxin <0.01EU/AXaUSPU <0.01EU/AXaUSPU
Filling volume Should meet the requirement. Complies
Free sulfate content  ≤0.12% 0.02%
Sterlity Should meet the requirement. Complies
Particulate matter ≥10um:not exceeding 6000
225μm:not exceeding 600
8vial
0/vial
Anti-factor Xa potency 90.0%-110.0% of stated potency 100.8%
Anti-factor lla potency 20.0%~35.0% of Anti-factor Xa potency 23.4%
High Qualified Enoxaparin Sodium Injection 40mg/0.4ml Anmedicine Ticoagulants


High Qualified Enoxaparin Sodium Injection 40mg/0.4ml Anmedicine TicoagulantsHigh Qualified Enoxaparin Sodium Injection 40mg/0.4ml Anmedicine TicoagulantsHigh Qualified Enoxaparin Sodium Injection 40mg/0.4ml Anmedicine Ticoagulants

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier